« Suicide Prevention Group Delivers Much Needed Message To Pennsylvania’s Elderly | Main | Caregivers Of Lung Transplant Patients At Greater Risk Of Depression And PTSD Symptoms »
Wyeth’s Pristiq, A New Treatment For Major Depressive Disorder
By Depressed Jane | May 19, 2008
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that PRISTIQTM (desvenlafaxine), a new serotonin-norepinephrine reuptake inhibitor (SNRI) approved to treat adult patients with major depressive disorder (MDD), is now available in U.S. retail pharmacies nationwide. The recommended dose of PRISTIQ is 50 milligrams (mg) once daily. The Company begins full-scale selling and educational efforts regarding PRISTIQ for physicians this week.
Topics: A Depressed Life |